PT Diastika Biotekindo Tbk (ISX:CHEK) ROE %: 0.00% (As of . 20)


ISX:CHEK PT Diastika Biotekindo Tbk ISX:CHEK
2 GF Score
Price Rp125.00
! 1 Warning Sign
View Full Analysis

What is PT Diastika Biotekindo Tbk ROE %?

PT Diastika Biotekindo Tbk ISX:CHEK 2 ROE % is 0.00% as of . 20. GuruFocus rates ISX:CHEK with a GF Score™ of 2/100. The stock has 1 warning sign investors should review. Among 798 Medical Devices & Instruments companies, PT Diastika Biotekindo Tbk ranks worse than 125313.16% on this metric.

ROE % is calculated as Net Income divided by its average Total Stockholders Equity over a certain period of time. PT Diastika Biotekindo Tbk's annualized net income for the quarter that ended in . 20 was Rp Mil. PT Diastika Biotekindo Tbk's average Total Stockholders Equity over the quarter that ended in . 20 was Rp Mil. Therefore, PT Diastika Biotekindo Tbk's annualized ROE % for the quarter that ended in . 20 was %.

The historical rank and industry rank for PT Diastika Biotekindo Tbk's ROE % or its related term are showing as below:

ISX:CHEK's ROE % is not ranked *
in the Medical Devices & Instruments industry.
Industry Median: 2.395
* Ranked among companies with meaningful ROE % only.

PT Diastika Biotekindo Tbk  (ISX:CHEK) ROE % Explanation

ROE % measures the rate of return on the ownership interest (shareholder's equity) of the common stock owners. It measures a firm's efficiency at generating profits from every unit of shareholders' equity (also known as net assets or assets minus liabilities). ROE % shows how well a company uses investment funds to generate earnings growth. ROE %s between 15% and 20% are considered desirable.

The factors that affect a company's ROE % can be illustrated with the three-step DuPont Analysis:

ROE %(Q: . 20 )
=Net Income/Total Stockholders Equity
=/
=(Net Income / Revenue )*(Revenue / Total Assets)*(Total Assets / Total Stockholders Equity)
=( / )*( / )*( / )
=Net Margin %*Asset Turnover*Equity Multiplier
= %**
=ROA %*Equity Multiplier
= %*
= %

With this breakdown, it is clear that if a company grows its Net Profit Margin, its Asset Turnover, or its Leverage, it can grow its ROE %.

The factors that affect a company's ROE % can also be illustrated with the five-step DuPont Analysis:

ROE %(Q: . 20 )
=Net Income/Total Stockholders Equity
=/
=(Net Income / Pre-Tax Income) * (Pre-Tax Income / Operating Income) * (Operating Income / Revenue) * (Revenue / Total Assets) * (Total Assets / Total Stockholders Equity)
= ( / ) * ( / ) * ( / ) * ( / ) * ( / )
= Tax Burden * Interest Burden * Operating Margin % * Asset Turnover * Equity Multiplier
= * * % * *
= %

Note: The net income data used here is one times the annual (. 20) net income data. The Revenue data used here is one times the annual (. 20) revenue data. The same rule applies to Pre-Tax Income and Operating Income.
* In the five-step DuPont Analysis, Operating Income is only available for non-financial companies. Thus, for Insurance companies, we use EBIT as a substitution of Operating Income. For Banks, both Operating Income and EBIT is unavailable. Thus we combined Interest Burden and Operating Margin % into Pretax Margin %, and the DuPont Analysis is divided into four components instead.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Be Aware

Net Income is used.

Because a company can increase its ROE % by having more financial leverage, it is important to watch the equity multiplier when investing in high ROE % companies. Like ROA %, ROE % is calculated with only 12 months data. Fluctuations in company's earnings or business cycles can affect the ratio drastically. It is important to look at the ratio from a long term perspective.

Asset light businesses require very few assets to generate very high earnings. Their ROE %s can be extremely high.


PT Diastika Biotekindo Tbk ROE % Related Terms


PT Diastika Biotekindo Tbk ROE % Historical Data

* Premium members only.

The historical data trend for PT Diastika Biotekindo Tbk's ROE % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

PT Diastika Biotekindo Tbk ROE % Chart

PT Diastika Biotekindo Tbk Annual Data
Trend
ROE %

PT Diastika Biotekindo Tbk Semi-Annual Data
ROE %

ISX:CHEK vs ABT, SYK, MDT: ROE % Comparison

For the Medical Devices subindustry, PT Diastika Biotekindo Tbk's ROE %, along with its competitors' market caps and ROE % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


PT Diastika Biotekindo Tbk ROE % vs Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, PT Diastika Biotekindo Tbk's ROE % distribution charts can be found below:

* The bar in red indicates where PT Diastika Biotekindo Tbk's ROE % falls into.


ISX:CHEK
2GF Score
PT Diastika Biotekindo Tbk ISX:CHEK
ROE % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

PT Diastika Biotekindo Tbk ROE % Calculation

PT Diastika Biotekindo Tbk's annualized ROE % for the fiscal year that ended in . 20 is calculated as

ROE %=Net Income (A: . 20 )/( (Total Stockholders Equity (A: . 20 )+Total Stockholders Equity (A: . 20 ))/ count )
=/( (+)/ )
=/
= %

PT Diastika Biotekindo Tbk's annualized ROE % for the quarter that ended in . 20 is calculated as

ROE %=Net Income (Q: . 20 )/( (Total Stockholders Equity (Q: . 20 )+Total Stockholders Equity (Q: . 20 ))/ count )
=/( (+)/ )
=/
= %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

In the calculation of annual ROE %, the net income of the last fiscal year and the average total shareholder equity over the fiscal year are used. In calculating the quarterly data, the net income data used here is one times the annual (. 20) net income data. ROE % is displayed in the 30-year financial page.

* Note that if the average Total Stockholders Equity is zero or negative, then ROE % would be considered meaningless and hence not be calculated.

Frequently Asked Questions Learn more about ROE % →
What does a ROE % of 0.00% mean?
PT Diastika Biotekindo Tbk (ISX:CHEK) has a ROE % of 0.00% as of . 20. Return on equity is the ratio of current-period net income to average two-period total equity. View historical data on PT Diastika Biotekindo Tbk and its competitors. According to the industry distribution chart, PT Diastika Biotekindo Tbk ranks #999999 out of 798 companies in the Medical Devices & Instruments industry.
Is PT Diastika Biotekindo Tbk's ROE % too high?
PT Diastika Biotekindo Tbk's current ROE % is 0.00%. Based on the distribution chart, PT Diastika Biotekindo Tbk ranks #999999 out of 798 companies in the Medical Devices & Instruments industry, which is in the bottom quartile relative to peers. Overall, PT Diastika Biotekindo Tbk has a GF Score™ of 2/100, reflecting its overall financial health beyond just this single metric.
How does PT Diastika Biotekindo Tbk's ROE % compare to ABT and SYK?
According to the Medical Devices & Instruments industry distribution chart, PT Diastika Biotekindo Tbk ranks #999999 out of 798 companies for ROE %. This places PT Diastika Biotekindo Tbk in the lower half of its industry. The industry median ROE % is 2.40. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good ROE % for a Medical Devices & Instruments company?
The median ROE % among Medical Devices & Instruments companies is 2.40, based on 798 companies in the industry. Companies in the top quartile (top 25%) have a ROE % significantly above this median, while those in the bottom quartile fall well below. However, ROE % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high ROE % mean?
A high ROE % can signal that a stock is expensive relative to its fundamentals. Return on equity is the ratio of current-period net income to average two-period total equity. View historical data on PT Diastika Biotekindo Tbk and its competitors. For the Medical Devices & Instruments industry, the median ROE % is 2.40 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. PT Diastika Biotekindo Tbk's current ROE % is 0.00%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is PT Diastika Biotekindo Tbk stock overvalued right now?
PT Diastika Biotekindo Tbk (ISX:CHEK) has a current ROE % of 0.00%. The current ROE % is 0.00%. PT Diastika Biotekindo Tbk's overall GF Score™ is 2/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is ROE % calculated?
ROE % is calculated from a company's financial statements. For PT Diastika Biotekindo Tbk (ISX:CHEK), the current ROE % is 0.00% as of . 20. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

PT Diastika Biotekindo Tbk Business Description

Address Jalan Rawagelam V, Kawasan Industri Pulogadung, Block L, No. Kav 11-13, Gedung Etana Lantai 3, Desa/Kelurahan Jatinegara, Kec. Cakung, Kota Adm. Jakarta Timur, Jakarta, IDN, 13930
PT Diastika Biotekindo Tbk is engaged in providing medical and laboratory equipment solutions in Indonesia. It is engaged in the wholesale trading of laboratory equipment, pharmaceutical products, and medical devices for human use. The company is also involved in wholesale trading of radioactive substances and ionizing radiation generators, and undertakes activities related to the testing and/or calibration of medical devices, as well as the inspection of healthcare facilities and infrastructure. Its product offerings mainly include devices like hematology analyzer, pipette, hemoglobin testing system, etc. The company's operating segments are: Diagnostics Group, which generates the maximum revenue, and Life Sciences Group. Geographically, all of its revenue is derived from Indonesia.
2GF Score

Get the complete analysis for ISX:CHEK

ROE % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

Rp125.00
Price